Fig. 4
From: Application of RNAi-induced gene expression profiles for prognostic prediction in breast cancer
Prognosis of Ur-Rehman and Vijver breast cancer patients using RIPSRAD51. a Kaplan–Meier plot of RIPSRAD51 in Ur-Rehman database. Patients with higher cell proliferation (RIPS >0, red curve) shows worse survival prognosis. b Kaplan–Meier plot of RIPSRAD51 for ER+ patient samples in Ur-Rehman data. Patients with higher cell proliferation (red curve) show worse survival prognosis. c Kaplan–Meier plot of RIPSRAD51 for ER– patient samples in Ur-Rehman data. d Kaplan–Meier plot of RIPSRAD51 in Vijver database. Patients with higher cell proliferation (RIPS >0, red curve) shows worse survival prognosis. e Kaplan–Meier plot of RIPSRAD51 for Vijver ER+ patient samples. Patients with higher cell proliferation (red curve) show worse survival prognosis. f Kaplan–Meier plot of RIPSRAD51 for Vijver ER– patient samples.